Skip to main content

. 1979 Jun;72(6):397–399. doi: 10.1177/014107687907200602

Intelligence and prenatal progesterone: a reappraisal.

PMCID: PMC1437068 PMID: 552532

397

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Barker D. J., Edwards J. H. Obstetric complications and school performance. Br Med J. 1967 Sep 16;3(5567):695–699. doi: 10.1136/bmj.3.5567.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
DALTON K. Toxaemia of pregnancy treated with progesterone during the symptomatic stage. Br Med J. 1957 Aug 17;2(5041):378–381. doi: 10.1136/bmj.2.5041.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
Dalton K. Ante-natal progesterone and intelligence. Br J Psychiatry. 1968 Nov;114(516):1377–1382. doi: 10.1192/bjp.114.516.1377. [DOI] [PubMed] [Google Scholar]
Dalton K. Prenatal progesterone and educational attainments. Br J Psychiatry. 1976 Nov;129:438–442. doi: 10.1192/bjp.129.5.438. [DOI] [PubMed] [Google Scholar]
Dobbing J., Smart J. L. Vulnerability of developing brain and behaviour. Br Med Bull. 1974 May;30(2):164–168. doi: 10.1093/oxfordjournals.bmb.a071188. [DOI] [PubMed] [Google Scholar]
REIFENSTEIN E. C., Jr Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in habitual abortion. Ann N Y Acad Sci. 1958 Jul 30;71(5):762–786. doi: 10.1111/j.1749-6632.1958.tb46806.x. [DOI] [PubMed] [Google Scholar]
WILKINS L. Masculinization of female fetus due to use of orally given progestins. J Am Med Assoc. 1960 Mar 5;172:1028–1032. doi: 10.1001/jama.1960.03020100036007. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES